FIELD: medicine.
SUBSTANCE: claimed is cold-adapted strain of influenza virus A/Krasnodar/101/59/35 (H2N2) for obtaining reassortant strains of live influenza vaccine.
EFFECT: invention can be used in production of live cold-adapted attenuated anti-influenza vaccine.
1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COLD-ADAPTED INFLUENZA VIRUS STRAIN B-B/VICTORIA/2/63/87 INTENDED AS STRAIN-DONOR OF ATTENUATION FOR OBTAINING REASSORTANTS OF COLD-ADAPTED STRAINS FOR LIVE INFLUENZA VACCINE | 2013 |
|
RU2529772C1 |
| METHOD FOR OBTAINING ATTENUATED STRAINS OF INFLUENZA A VIRUS - CANDIDATES FOR LIVE INFLUENZA VACCINES | 2017 |
|
RU2670514C1 |
| METHOD FOR IMPROVING IMMUNOGENICITY OF COLD-ADAPTED LIVE INFLUENZA VACCINE | 2010 |
|
RU2465006C2 |
| ATTENUATED COLD-ADAPTED INFLUENZA VIRUS STRAIN A/PR/8/59/M2 (H1N1) APPLICABLE FOR VACCINAL INFLUENZA VIRUS STRAINS AS ATTENUATION DONOR, VACCINAL INFLUENZA VIRUS STRAINS A/59/M2/CALIFORNIA/66/2211 (H2N2) AND A/59/M2/TOKYO/67/22111 (H2N2) | 2011 |
|
RU2556833C2 |
| STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2011/89 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2012 |
|
RU2532844C2 |
| INFLUENZA VIRUS STRAIN A/17/Anui/2013/61 (H7N9) FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE | 2013 |
|
RU2563351C2 |
| VACCINE STRAIN OF A/17/BRISBANE/07/28 (H1N1) INFLUENZA VIRUS FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2010 |
|
RU2416641C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/CALIFORNIA/04/6 (H3N2) AND ATTENUATION DONOR A/LENINGRAD/134/17/K7/57 (H2N2) FOR ITS PREPARING | 2006 |
|
RU2315101C2 |
| INFLUENZA VIRUS STRAIN A/Hongkong/1/68/162/35 (H3N2) - UNIVERSAL DONOR OF INTERNAL GENES FOR REASSORTANTS, AND REASSORTANT STRAINS A/SPB/GK/09 (H1N1) AND A/HK/Astana/6:2/2010 (H5N1) PREPARED THEREOF | 2011 |
|
RU2511431C2 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/SLOVENIA/2015/1121 (H1N1)PDM09 FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2724706C1 |
